Exane Derivatives’s Antares Pharma, Inc. ATRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-104
| Closed | -$426 | – | 1063 |
|
|
2022
Q1 | $426 | Sell |
104
-11,386
| -99% | -$46.6K | ﹤0.01% | 882 |
|
|
2021
Q4 | $41K | Sell |
11,490
-24,895
| -68% | -$88.9K | 0.01% | 512 |
|
|
2021
Q3 | $132K | Buy |
36,385
+2,139
| +6% | +$7.79K | 0.03% | 477 |
|
|
2021
Q2 | $150K | Buy |
+34,246
| New | +$150K | 0.03% | 469 |
|
|
2021
Q1 | – | Sell |
-1,613
| Closed | -$6.44K | – | 969 |
|
|
2020
Q4 | $6.44K | Hold |
1,613
| – | – | ﹤0.01% | 531 |
|
|
2020
Q3 | $4.36K | Sell |
1,613
-29,881
| -95% | -$80.7K | ﹤0.01% | 491 |
|
|
2020
Q2 | $86.6K | Sell |
31,494
-317
| -1% | -$872 | 0.02% | 296 |
|
|
2020
Q1 | $75.1K | Buy |
+31,811
| New | +$75.1K | 0.02% | 301 |
|